Comparisons of vaccine effectiveness among three vaccines of respiratory syncytial virus for adults. These data showed that vaccine effectiveness for the patients with three and more than three symptoms f lower respiratory tract illness (LRTI) in season 1 and season 2. Blue circles: Abrysvo (Pfizer), Black circles: Arexvy (GSK), Red circles: mRNA-1245 (Moderna), respectively.